They found significantly a lower trabecular bone volume and near-significant lower trabecular thickness values in the discontinuation group compared to the denosumab-treated group.
← all excerpts
Trabecular bone deterioration in a postmenopausal female suffering multiple spontaneous vertebral fractures due to a delayed denosumab injection - A post-treatment re-initiation bone biopsy-based case study.
1
—
—